| Year |
Citation |
Score |
| 2020 |
Cordova C, Syeda MM, Corless B, Wiggins JM, Patel A, Kurz SC, Delara M, Sawaged Z, Utate M, Placantonakis D, Golfinos J, Schafrick J, Silverman JS, Jain R, Snuderl M, et al. Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patients Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-A65 |
0.349 |
|
| 2019 |
Cordova C, Syeda MM, Corless B, Wiggins JM, Patel A, Kurz SC, Delara M, Sawaged Z, Utate M, Placantonakis D, Golfinos J, Schafrick J, Silverman JS, Jain R, Snuderl M, et al. Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using TERT promoter mutation-specific droplet digital PCR assays. Journal of Clinical Oncology. 37: 2026-2026. DOI: 10.1200/Jco.2019.37.15_Suppl.2026 |
0.301 |
|
| 2019 |
Kurz S, Silverman JS, Hochman T, Nayak L, Arrillaga-Romany I, Lee E, Patel A, Delara M, Hsu F, Imtiaz T, Magnelli L, Taylor J, Cloughesy T, Sulman E, Golfinos J, et al. ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM) Neuro-Oncology. 21: vi9-vi10. DOI: 10.1093/Neuonc/Noz175.036 |
0.321 |
|
| 2019 |
Cooper BT, Shenker RF, Oh C, Tyburczy A, Golfinos J, Silverman JS, Kondziolka D. A Prospective Observational Study Correlating Peripheral Biomarkers Associated with Changes to the Blood-Brain Barrier and Tumor Volume in Patients Treated with Radiation for Intracranial Metastases International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2329 |
0.351 |
|
| 2017 |
Cordova C, Corless B, Syeda M, Patel A, Delara M, Eisele S, Schafrick J, Placantonakis D, Pacione D, Silverman J, Fatterpekar G, Shepherd T, Jain R, Snuderl M, Zagzag D, ... Golfinos J, et al. PATH-42. DETECTION OF TERT MUTATIONS IN CELL-FREE CIRCULATING TUMOR DNA (ctDNA) OF GLIOBLASTOMA PATIENTS USING DROPLET DIGITAL PCR Neuro-Oncology. 19: vi180-vi180. DOI: 10.1093/Neuonc/Nox168.732 |
0.305 |
|
| 2015 |
Weiss S, Darvishian F, Tadepalli J, Shapiro R, Golfinos J, Pavlick A, Polsky D, Kirchhoff T, Osman I. Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis. Bmc Cancer. 15: 926. PMID 26597176 DOI: 10.1186/S12885-015-1927-0 |
0.351 |
|
| 2015 |
Jain R, Griffith B, Alotaibi F, Zagzag D, Fine H, Golfinos J, Schultz L. Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade. Ajnr. American Journal of Neuroradiology. PMID 26206809 DOI: 10.3174/Ajnr.A4405 |
0.305 |
|
| 2015 |
Osorio D, Filatov A, Hagiwara M, Mitchell C, Wisoff J, Golfinos J, Roland JT, Allen J, Karajannis M. TR-13 * EFFECTS OF EVEROLIMUS ON MENINGIOMA GROWTH IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2 Neuro-Oncology. 17: iii39-iii39. DOI: 10.1093/Neuonc/Nov061.158 |
0.37 |
|
| 2012 |
Narayana A, Kunnakkat SD, Medabalmi P, Golfinos J, Parker E, Knopp E, Zagzag D, Eagan P, Gruber D, Gruber ML. Change in pattern of relapse after antiangiogenic therapy in high-grade glioma. International Journal of Radiation Oncology, Biology, Physics. 82: 77-82. PMID 21163583 DOI: 10.1016/J.Ijrobp.2010.10.038 |
0.355 |
|
| 2011 |
Narayana A, Perretta D, Kunnakkat S, Gruber D, Golfinos J, Parker E, Medabalmi P, Zagzag D, Pat Eagan RN, Gruber M. Invasion is not an independent prognostic factor in high-grade glioma. Journal of Cancer Research and Therapeutics. 7: 331-5. PMID 22044816 DOI: 10.4103/0973-1482.87039 |
0.359 |
|
| 2010 |
Gruber ML, Kunnakkat S, Medabalmi P, Gruber DB, Golfinos J, Parker E, Narayana A. Change in pattern of relapse in newly diagnosed high-grade glioma following bevacizumab therapy. Journal of Clinical Oncology. 28: 2020-2020. DOI: 10.1200/Jco.2010.28.15_Suppl.2020 |
0.317 |
|
| 2010 |
Narayana A, Kunnakkat S, Medabalmi P, Golfinos J, Parker E, Knopp E, Zagzag D, Gruber D, Gruber ML. Abstract 5336: Change in pattern of relapse following anti-angiogenic therapy in high grade gliomas Cancer Research. 70: 5336-5336. DOI: 10.1158/1538-7445.Am10-5336 |
0.377 |
|
| 2009 |
Narayana A, Kelly P, Golfinos J, Parker E, Johnson G, Knopp E, Zagzag D, Fischer I, Raza S, Medabalmi P, Eagan P, Gruber ML. Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. Journal of Neurosurgery. 110: 173-80. PMID 18834263 DOI: 10.3171/2008.4.17492 |
0.373 |
|
| 2009 |
Raza S, Narayana A, Morsi A, Parker E, Rush S, Golfinos J, Novik Y. Outcomes of Stereotactic Radiosurgery in the Management of Brain Metastasis in Patients with HER2 Positive Metastatic Breast Cancer. Cancer Research. 69: 6152-6152. DOI: 10.1158/0008-5472.Sabcs-09-6152 |
0.339 |
|
| 2006 |
Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Neurosurgery. 58: 1099-107; discussion. PMID 16723889 DOI: 10.1227/01.Neu.0000215944.81730.18 |
0.387 |
|
| 2004 |
Law M, Hamburger M, Johnson G, Inglese M, Londono A, Golfinos J, Zagzag D, Knopp EA. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging. Technology in Cancer Research & Treatment. 3: 557-65. PMID 15560713 DOI: 10.1177/153303460400300605 |
0.303 |
|
| Show low-probability matches. |